Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Leadership & People

Set Alert for Leadership & People

Back To The Day Job? AstraZeneca’s Pangalos Looks Ahead To A Post-Pandemic Pipeline

Has AstraZeneca been able to maintain its R&D productivity, even during a pandemic, and with the huge task of delivering a not-for-profit COVID-19 vaccine to the world?AstraZeneca’s Mene Pangalos believes the company has not missed a beat, and can find new energy from finally working together in its new R&D headquarters.

Coronavirus COVID-19 Business Strategies

Merck & Co. CEO Davis Debuts With A Leaner Organization And Money To Spend

Merck's new CEO Robert Davis talked about his vision for business development and how the company might use the $9bn gained from the spinout of Organon.

Sales & Earnings Deals

Executives On The Move: New SVP Of Oncology Clinical Research At Gilead, While EyeGate Gets New CEO

New chief medical officer at SpringWorks Therapeutics, while Biomea Fusion gets new chief financial officer.

Appointments BioPharmaceutical

Biogen Fires Back At Critics In Defense Of Aduhelm

Management tried to sidestep controversy around the approval of Aduhelm and said it remains confident the drug will be reimbursed.

Sales & Earnings Neurology

Helixmith Shareholders Fail In Bid To Oust Top Management

Relief for Helixmith’s management as voting at recent shareholders' meeting failed to remove top executives, including the South Korean biotech’s founder and CEO, following recent setbacks. But the future of the board may now depend largely on the success of the ongoing clinical trials for lead assets and stock price recovery.

South Korea Leadership

Executives On The Move: New Chief Scientific Officers At Almirall And FibroGen

Chief brand officer joins Moderna, plus new chief medical officer at Monopar Therapeutics.

Appointments BioPharmaceutical

Fundraising Tips From The Top Of European Biotech

The biotech sector is awash with capital and the rise of the virtual roadshow is breaking down geographic barriers, giving European firms a better chance to impress US investors.

Financing Leadership

Executives On The Move: New Chief Financial Officer Joins BioNTech, While Moderna Picks Up New Chief Medical Officer

Merck Gets New Chief Strategy Officer, New Chief Operating And Production Officer At CureVac.

Appointments Leadership

GSK's Oncology R&D Chief Axel Hoos Jumps To Lead Scorpion

Axel Hoos will become the CEO of a Boston-based cancer start-up focusing on targeted precision drugs. He talked to Scrip about the decision to leave GSK after 10 years.

Leadership Companies

Executives On The Move: New CEOs For Lengo, Draupnir And OncoSec

Leadership moves are also reported at CureVac, while Esperion Therapeutics and Palatin Technologies get new chief medical officers.

Appointments BioPharmaceutical

Pharma Veteran Sørensen To Help Guide Ferring's Growth Plans

After more than three decades being associated with Novo Nordisk, Lars Rebien Sørensen has signed up to be chairman of Ferring, telling Scrip that the privately owned Swiss group's philosophy chimes with his own.

Leadership Business Strategies
See All
UsernamePublicRestriction

Register